Osaic Holdings
INMB icon

Osaic Holdings’s INmune Bio INMB Stock Holding History

Osaic Holdings’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Buy
11,300
+7,735
+217% +$10.7K ﹤0.01% 6233
2026
Q1 		$4.03K Sell
3,565
-600
-14% -$855 ﹤0.01% 6785
2025
Q4 		$6.5K Sell
4,165
-950
-19% -$1.7K ﹤0.01% 6558
2025
Q3 		$10.5K Sell
5,115
-7,395
-59% -$16.9K ﹤0.01% 6326
2025
Q2 		$28.9K Sell
12,510
-1,415
-10% -$10.4K ﹤0.01% 5432
2025
Q1 		$109K Buy
13,925
+11,625
+505% +$92.3K ﹤0.01% 4107
2024
Q4 		$10.7K Sell
2,300
-4,400
-66% -$22.9K ﹤0.01% 5759
2024
Q3 		$36.1K Sell
6,700
-1,463
-18% -$10.4K ﹤0.01% 4970
2024
Q2 		$72K Sell
8,163
-4,107
-33% -$40.5K ﹤0.01% 4387
2024
Q1 		$144K Buy
12,270
+1,570
+15% +$19K ﹤0.01% 3955
2023
Q4 		$120K Buy
10,700
+2,200
+26% +$18.4K ﹤0.01% 4298
2023
Q3 		$57.5K Sell
8,500
-2,700
-24% -$22.4K ﹤0.01% 4898
2023
Q2 		$102K Buy
11,200
+3,265
+41% +$26.2K ﹤0.01% 4419
2023
Q1 		$51.3K Sell
7,935
-1,315
-14% -$10.6K ﹤0.01% 4935
2022
Q4 		$59K Buy
9,250
+3,200
+53% +$22.7K ﹤0.01% 4809
2022
Q3 		$38K Buy
6,050
+493
+9% +$4.33K ﹤0.01% 5096
2022
Q2 		$49K Sell
5,557
-27,543
-83% -$205K ﹤0.01% 4978
2022
Q1 		$279K Sell
33,100
-2,638
-7% -$23.7K ﹤0.01% 3742
2021
Q4 		$364K Buy
35,738
+23,568
+194% +$349K ﹤0.01% 3378
2021
Q3 		$237K Sell
12,170
-15,092
-55% -$291K ﹤0.01% 3747
2021
Q2 		$479K Buy
27,262
+19,280
+242% +$260K ﹤0.01% 3075
2021
Q1 		$94K Buy
7,982
+1,982
+33% +$35.7K ﹤0.01% 4397
2020
Q4 		$103K Hold
6,000
– – ﹤0.01% 4013
2020
Q3 		$62K Buy
6,000
+5,800
+2,900% +$59K ﹤0.01% 4149
2020
Q2 		$1K Sell
200
-100
-33% -$504 ﹤0.01% 5947
2020
Q1 		$1K Buy
+300
New +$1.35K ﹤0.01% 5863

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings's INMB Position: Q2 2026 in Review

Osaic Holdings increased its INmune Bio (INMB) stake by 217% in Q2 2026, buying an estimated $10.7K and bringing the position to 11,300 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6233.

Osaic Holdings first reported a position in INMB in Q1 2020 and has held it in 26 quarters since. The position peaked at $479K in Q2 2021. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Osaic Holdings held 11,300 shares of INmune Bio worth $18.4K as of Q2 2026.
  • Osaic Holdings bought 7,735 INmune Bio shares in Q2 2026, an estimated $10.7K.
  • INmune Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6233 holding.
  • Osaic Holdings first reported a position in INmune Bio in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's INmune Bio position peaked at $479K in Q2 2021.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.